Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
2013 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trial
1992
Thrombolysis for pulmonary embolism
1991
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Gross Versus Microscopic Pancolitis and the Occurrence of Neoplasia in Ulcerative Colitis
2003
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Changes in Extent of Ulcerative Colitis A Study on the Course and Prognostic Factors
1996
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
2014
Perioperative Management of Antithrombotic Therapy
2012 Standout
Embolic strokes of undetermined source: the case for a new clinical construct
2014 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Thrombolysis vs Heparin in the Treatment of Pulmonary Embolism
2002
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
1999 Standout
Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes
2000 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Congenital Heart Surgery Nomenclature and Database Project: anomalies of the coronary arteries
2000
Thrombolytic therapy of pulmonary embolism
2002
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Ulcerative colitis
2012 Standout
Thrombolytic therapy for pulmonary embolism
2009
Executive Summary
2012 Standout
Thrombolytic Therapy for Acute Pulmonary Embolism
2009
Ulcerative Colitis
1998
Streptokinase vs alteplase in massive pulmonary embolism: A randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction
1997
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Thrombolytic Therapy: Current Status
1988
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Major Pulmonary Embolism
2002
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*
2006 Standout
Change in The Extent of Colonoscopic and Histological Involvement in Ulcerative Colitis Over Time
1999
Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but Underused
2012
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Sudden cardiac death associated with isolated congenital coronary artery anomalies
1992 Standout
Thrombolytic therapy of acute pulmonary embolism: Current status and future potential
1987
Novel management strategy for patients with suspected pulmonary embolism
2003
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary Embolism
2002 Standout
Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography
2010 Standout
Comparative Efficacy of a Two-Hour Regimen of Streptokinase Versus Alteplase in Acute Massive Pulmonary Embolism: Immediate Clinical and Hemodynamic Outcome and One-Year Follow-Up 11This study was partly supported by grants from Programme Hospitalier de la Recherche Clinique (Ministère de la Santé Publique), Paris; Boehringer Ingelheim, Reims Cedex, France; and Hoechst France, Puteaux, France.
1998
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Congenital coronary arteriovenous fistula. Report of 13 patients, review of the literature and delineation of management.
1979 Standout
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism
2004
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
Sudden Death in Young Adults: A 25-Year Review of Autopsies in Military Recruits
2004 Standout
Part 9: Post–Cardiac Arrest Care
2010 Standout
Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases.
1988
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin.
1996
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Histologic and Colonoscopic Assessment of Disease Extension in Ulcerative Colitis
1987
Congenital Coronary Artery Fistula with Myocardial Infarction
1974
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Recurrence of pulmonary embolism during anticoagulant treatment: a prospective study.
1987
Major anomalies of coronary arterial origin seen in adulthood
1986
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The Use of Thrombolytic Agents: Choice of Patient, Drug Administration, Laboratory Monitoring
1979
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Right ventricular function in adult cardiovascular disease
1982
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM
1995
Coronary Artery Anomalies
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Congenital Coronary Artery—Cardiac Chamber Fistula
1975
The role of thrombolytic therapy in pulmonary embolism
2015
Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
2014
Sustained improvement of pulmonary hemodynamics in patients at rest and during exercise after thrombolytic treatment of massive pulmonary embolism.
1985
Works of Harald Eie being referenced
Arterio-Venous Fistulae of the Coronary Arteries:A Report of Six Cases
1971
The Diagnosis of Colitis by Colonoscopy with Biopsy and X-ray Examination. A Blind Comparative Study
1976
CORONARY ANGIOGRAPHY AND ANGINA PECTORIS
1970
A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism
1978
SINGLE CORONARY ARTERY
1971